A meningitis B (MenB) vaccination programme targeting young people and university students in Northern Ireland will roll out from 31 July, NI's chief medical officer has said. It follows an outbreak in England earlier this year, in which two people - a university student and a sixth-form pupil - died. The two-dose vaccine will be offered to those deemed most at risk from the infection, including Year 14 students and under-25s starting university or a Higher Education institution for the first time this autumn. MenB is a bacterial infection that can cause serious, life-threatening illness including inflammation of the lining of the brain and blood poisoning (sepsis). It is spread by close contact such as kissing, sharing vapes or drinks, or living in close quarters - like student accommodation - with a person who has the disease.

High street pharmacies across England are now offering a free meningitis B vaccine for many young people. It comes after concerns over the UK's largest and fastest growing outbreak that happened in Kent earlier this year. So who needs the vaccine and what's in it? What's the vaccine and is it safe? The vaccine offers protection against a dangerous strain of meningitits called meningitis B (MenB) that caused the outbreak in Kent. The vaccine does not contain any live bacteria and cannot cause meningitis.